The global impact of the COVID-19 pandemic on the management and course of chronic urticaria.
Kocatürk E, Salman A, Cherrez-Ojeda I, Criado PR, Peter J, Comert-Ozer E, Abuzakouk M, Agondi RC, Al-Ahmad M, Altrichter S, Arnaout R, Arruda LK, Asero R, Bauer A, Ben-Shoshan M, Bernstein JA, Bizjak M, Boccon-Gibod I, Bonnekoh H, Bouillet L, Brzoza Z, Busse P, Campos RA, Carne E, Conlon N, Criado RF, de Souza Lima EM, Demir S, Dissemond J, Doğan Günaydın S, Dorofeeva I, Ensina LF, Ertaş R, Ferrucci SM, Figueras-Nart I, Fomina D, Franken SM, Fukunaga A, Giménez-Arnau AM, Godse K, Gonçalo M, Gotua M, Grattan C, Guillet C, Inomata N, Jakob T, Karakaya G, Kasperska-Zając A, Katelaris CH, Košnik M, Krasowska D, Kulthanan K, Kumaran MS, Lang C, Larco-Sousa JI, Lazaridou E, Leslie TA, Lippert U, Llosa OC, Makris M, Marsland A, Medina IV, Meshkova R, Palitot EB, Parisi CAS, Pickert J, Ramon GD, Rodríguez-Gonzalez M, Rosario N, Rudenko M, Rutkowski K, Sánchez J, Schliemann S, Sekerel BE, Serpa FS, Serra-Baldrich E, Song Z, Soria A, Staevska M, Staubach P, Tagka A, Takahagi S, Thomsen SF, Treudler R, Vadasz Z, Valle SOR, Van Doorn MBA, Vestergaard C, Wagner N, Wang D, Wang L, Wedi B, Xepapadaki P, Yücel E, Zalewska-Janowska A, Zhao Z, Zuberbier T, Maurer M.
Kocatürk E, et al. Among authors: lang c.
Allergy. 2021 Mar;76(3):816-830. doi: 10.1111/all.14687. Epub 2020 Dec 29.
Allergy. 2021.
PMID: 33284457
